Virtual Lymphoma Management Course 2023 - video access only

Our popular Lymphoma Management Course was delivered virtually during September and October 2023, and comprised of four weekly sessions, covering many key topics essential for the effective management of lymphomas, presented by our expert faculty. The content is suitable for healthcare professionals who spend at least some of their time treating patients with lymphoma.

The course is suitable for registrars looking to learn the evidence base for the diagnosis and management of lymphoma, as well as consultants, specialist nurses, pharmacists and other healthcare professional looking for a valuable update to their knowledge around research and practice.

The live sessions have now finished. Videos of the 4 sessions are available for access, and will remain online until 1 February 2024. 

Register to access the videos now (£60)

Important notes

• Registration can only be made online, and an online card payment must be made at the time of registering. We cannot take offline bookings, or create invoices for online events.
• Please ensure that you check the email address you enter into the booking system - as this is the email to which your confirmation email will be sent. Once you have registered, please check your emails for your confirmation email. This should come though within a few minutes. (You may need to check your 'junk' folder.)
• Your confirmation email on booking will contain the link and password to access the course materials (videos and documents). Please keep this email for reference as you will need the weblink and password in order to access the materials.

The course is a collaboration between Oxford Centre of Haematology and Lymphoma Action.

Programme

Week 1 – High-grade non-Hodgkin lymphoma: Diagnostics and DLBCL

• Why lymphoma is so interesting, Professor Graham Collins (Oxford)
• Integrated lymphoma diagnostics, Dr Cathy Burton (Leeds)
• Approach to the front-line management of diffuse large B-cell lymphoma, Dr Wendy Osborne (Newcastle)
• Relapsed and refractory diffuse large B-cell lymphoma, Professor Andy Davies (Southampton)

Week 2 – Hodgkin lymphoma

• Classical Hodgkin lymphoma: work up and first line treatment, Dr Beth Phillips (Manchester)
• Management of relapsed classical Hodgkin lymphoma, Professor Graham Collins (Oxford)
• Radiotherapy – weighting risks and benefits, Dr David Cutter (Oxford)
• Nodular LP Hodgkin lymphoma, Dr Pam McKay (Glasgow)

Week 3 – High-grade non-Hodgkin lymphoma: other entities

• Primary CNS Lymphoma: Work up and first line treatment, Dr Jeff Smith (Liverpool)
• Relapsed PCNSL and secondary CNS lymphoma, Professor Chris Fox (Nottingham)
• Peripheral T-cell lymphoma, Dr Kate Cwynarski (London)
• Harnessing T-cells to treat lymphoma, Dr Andrea Kuhnl (London)
• Post-transplant lymphoproliferative disease, Dr Sridhar Chaganti (Birmingham)

Week 4 - Indolent non-Hodgkin lymphoma

• Mantle Cell lymphoma , Dr Toby Eyre (Oxford)
• Follicular lymphoma, Dr Jessica Okosun (London)
• Marginal zone lymphoma, Dr Kim Linton (Manchester)
• Lymphoplasmacytic lymphoma/ Waldenstrom Macroglobulinaemia, Dr Jaimal Kothari (Oxford)

We would like to thank the course directors:

• Prof Graham Collins, Associate Professor of Haematology, Oxford University Hospitals.
• Dr Toby Eyre, Consultant Haematologist, Oxford University Hospitals. 

We would also like to thank the members of our steering group who gave their time to review the course content:

• Dr Wendy Osborne, Consultant Haematologist, Freeman Hospital, Newcastle.
• Dr Kate Cwynarski, Consultant Haematologist, University College London Hospital.

---